Development status: Approved, off-patent

Gram-positive activity

Mechanism of Action/Target pathogen: Inhibits the formation of late-stage peptidoglycan intermediates (lipid intermediates) by inhibiting lipid phosphorylase. Active against Gram-positive bacteria.

Additional information: Natural product produced by Bacillus licheniformis, composed of a mixture of related compounds. Used for minor skin wounds and eye infections often in combination with other antibiotics.